A non-invasive diagnosis of histiocytic necrotizing lymphadenitis by means of gene expression profile analysis of peripheral blood mononuclear cells

Journal of Clinical Immunology

Volumn 33, Issue 5, 2013, Pages 1018-1026

  Ishimura, Masataka ^a   Yamamoto, Hiroyuki ^a   Mizuno, Yumi ^b   Takada, Hidetoshi ^a   Goto, Motohiro ^a   Doi, Takehiko ^a   Hoshina, Takayuki ^a   Ohga, Shouichi ^a   Ohshima, Koichi ^c   Hara, Toshiro ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b FUKUOKA CHILDREN S HOSPITAL   (Japan)

^c KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

discriminate analysis; gene expression; Histiocytic necrotizing lymphadenitis; interferon stimulated genes; Kikuchi Fujimoto disease

Indexed keywords

GAMMA INTERFERON INDUCIBLE PROTEIN 10; TRANSCRIPTOME;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CXCL10 GENE; EPSTI1 GENE; FEMALE; GBP1 GENE; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IFI27 GENE; IFI44L GENE; INTERFERON INDUCED GENE; KIKUCHI DISEASE; LYMPH NODE; MALE; MICROARRAY ANALYSIS; NON INVASIVE MEASUREMENT; PERIPHERAL BLOOD MONONUCLEAR CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; UPREGULATION;

ADOLESCENT; BIOLOGICAL ASSAY; CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION PROFILING; HISTIOCYTIC NECROTIZING LYMPHADENITIS; HUMANS; LEUKOCYTES, MONONUCLEAR; LYMPH NODES; MALE; MICROARRAY ANALYSIS; TRANSCRIPTOME; UP-REGULATION;

EID: 84879243091     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-013-9897-y     Document Type: Article

References (23)

1. Bosch X, Guilabert A, Miquel R, Campo E. Enigmatic Kikuchi-Fujimoto disease: a comprehensive review. Am J Clin Pathol. 2004;122:141-52.
2. Hutchinson CB, Wang E. Kikuchi-Fujimoto disease. Arch Pathol Lab Med. 2010;134:289-93.
3. Yoshioka K, Miyashita T, Nakamura T, et al. Treatment of histiocytic necrotizing lymphadenitis (Kikuchi's disease) with prolonged fever by a single course of methylprednisolone pulse therapy without maintenance therapy: experience with 13 cases. Intern Med. 2010;49:2267-70.
4. Pileri SA, Facchetti F, Ascani S, et al. Myeloperoxidase expression by histiocytes in Kikuchi's and Kikuchi-like lymphadenopathy. Am J Pathol. 2001;159:915-24.
5. Pilichowska ME, Pinkus JL, Pinkus GS. Histiocytic necrotizing lymphadenitis (Kikuchi-Fujimoto disease): lesional cells exhibit an immature dendritic cell phenotype. Am J Clin Pathol. 2009;131:174-82.
6. Ohshima K, Shimazaki K, Kume T, et al. Perforin and Fas pathways of cytotoxic T-cells in histiocytic necrotizing lymphadenitis. Histopathology. 1998;33:471-8.
7. Ohshima K, Shimazaki K, Suzumiya J, et al. Apoptosis of cytotoxic T-cells in histiocytic necrotizing lymphadenitis. Virchows Arch. 1998;433:131-4.
8. Ohshima K, Karube K, Hamasaki M, et al. Apoptosis- and cell cycle-associated gene expression profiling of histiocytic necrotising lymphadenitis. Eur J Haematol. 2004;72:322-9.
9. Hu S, Kuo TT, Hong HS. Lupus lymphadenitis simulating Kikuchi's lymphadenitis in patients with systemic lupus erythematosus: a clinicopathological analysis of six cases and review of the literature. Pathol Int. 2003;53:221-6.
10. Sumiyoshi Y, Kikuchi M, Takeshita M, et al. Alpha-interferon in Kikuchi's disease. Virchows Arch B Cell Pathol Incl Mol Pathol. 1991;61:201-7.
11. Kubota M, Tsukamoto R, Kurokawa K, et al. Elevated serum interferon gamma and interleukin-6 in patients with necrotizing lymphadenitis (Kikuchi's disease). Br J Haematol. 1996;95:613-5.
12. Ikeda K, Yamaguchi K, Tanaka T, et al. Unique activation status of peripheral blood mononuclear cells at acute phase of Kawasaki disease. Clin Exp Immunol. 2010;160:246-55.
13. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008;3:1101-8.
14. Schoggins JW, Wilson SJ, Panis M, et al. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature. 2011;472:481-5.
15. Ohshima K, Haraoka S, Takahata Y, et al. Interferon-gamma, interleukin-18, monokine induced by interferon-gamma and interferon-gamma- inducible protein-10 in histiocytic necrotizing lymphadenitis. Leuk Lymphoma. 2002;43:1115-20.
16. Ishii T, Onda H, Tanigawa A, et al. Isolation and expression profiling of genes upregulated in the peripheral blood cells of systemic lupus erythematosus patients. DNA Res. 2005;12:429-39.
17. Ansell SM, Maurer MJ, Ziesmer SC, et al. Elevated pretreatment serum levels of interferon-inducible protein-10 (CXCL10) predict disease relapse and prognosis in diffuse large B-cell lymphoma patients. Am J Hematol. 2012;87:865-9.
18. Lee Y, Chittezhath M, Andre V, et al. Protumoral role of monocytes in human B-cell precursor acute lymphoblastic leukemia: involvement of the chemokine CXCL10. Blood. 2012;119:227-37.
19. Nzeusseu Toukap A, Galant C, Theate I, et al. Identification of distinct gene expression profiles in the synovium of patients with systemic lupus erythematosus. Arthritis Rheum. 2007;56:1579-88.
20. Naschberger E, Wenzel J, Kretz CC, et al. Increased expression of guanylate binding protein-1 in lesional skin of patients with cutaneous lupus erythematosus. Exp Dermatol. 2011;20:102-6.
21. Kimoto O, Sawada J, Shimoyama K, et al. Activation of the interferon pathway in peripheral blood of patients with Sjogren's syndrome. J Rheumatol. 2011;38:310-6.
22. Szturz P, Adam Z, Chovancová J, et al. Cytokine analysis in a patient with relapsing Kikuchi-Fujimoto disease. Leuk Lymphoma. 2012;53:743-5.
23. Itsui Y, Sakamoto N, Kakinuma S, et al. Antiviral effects of the interferon-induced protein guanylate binding protein 1 and its interaction with the hepatitis C virus NS5B protein. Hepatology. 2009;50:1727-37.